Inside firms, AI is changing tasks—and, with those tasks, how they hire and organize. Controlled studies show large gains on ...

The world of brain research has a secret flaw. For decades, studies into how the mind works have been carried out primarily by English-speaking scientists on English-speaking participants. Yet their ...

AI hallucinations are one of users’ biggest concerns when utilizing large language models (LLMs). And while many might expect front-runners like OpenAI and Anthropic to lead the way in addressing the ...

The first major finding is that while most cognitive skills in puppies develop surprisingly early, they develop independently ...

Backed by $200 million in funding, 28-year-old Scott Wu and his team of competitive coders at Cognition are building an AI tool that can program entirely on its own, like an “army of junior engineers.

Does epinephrine make you think differently? Could love make you illogical? The assumption that artificial intelligence would necessarily replicate human thought processes may be a fundamental ...

Cognition Therapeutics (CGTX) announced that its expanded access program has reached full enrollment. Each of the individuals enrolled in the ...

Amid an influx of new drugs targeting one of the believed root causes of Alzheimer’s disease, a new symptomatic med has hit the scene, courtesy of Vancouver’s Alpha Cognition. On Monday, the FDA gave ...

Cognition Therapeutics Inc (NASDAQ:CGTX) rose 12.10% to $0.45 during after hours on Thursday, following a surge of 20.82% gain during regular hours. What Happened: The hike in Cognition Therapeutics’ ...